Cristin-resultat-ID: 2044078
Sist endret: 14. februar 2023, 11:40
NVI-rapporteringsår: 2022
Resultat
Vitenskapelig artikkel
2022

Clinical experience of volumetric-modulated flattening filter free stereotactic body radiation therapy of lesions in the lung with deep inspiration breath-hold

Bidragsytere:
  • Siri Tessem Mørkeset
  • Christoffer Lervåg
  • Jo-Åsmund Lund og
  • Christer André Jensen

Tidsskrift

Journal of Applied Clinical Medical Physics
ISSN 1526-9914
e-ISSN 1526-9914
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2022
Publisert online: 2022
Volum: 23
Hefte: 9
Sider: 1 - 8
Artikkelnummer: e13733
Open Access

Importkilder

Scopus-ID: 2-s2.0-85134597706

Beskrivelse Beskrivelse

Tittel

Clinical experience of volumetric-modulated flattening filter free stereotactic body radiation therapy of lesions in the lung with deep inspiration breath-hold

Sammendrag

This clinical study aimed to evaluate lung cancer patients’ ability to perform deep inspiration breath-hold (DIBH) during CT simulation and throughout the treatment course of stereotactic body radiation therapy (SBRT). In addition, target sizes, organ at risk (OAR) sizes, and doses to the respective volumes in filter-free volumetric-modulated arc therapy plans performed under free-breathing (FB) and DIBH conditions were evaluated. Twenty-one patients with peripheral lesions were included, of which 13 were eligible for SBRT. All patients underwent training for breath-hold during CT, and if they complied with the requirements, two CT scans were obtained: CT scan in DIBH and a four-dimensional CT scan in FB. The treatment plans in FB and DIBH were generated, and the dose parameters and volume sizes were compared. The endpoints for evaluation were patient compliance, target dose coverage, and doses to the OARs. This clinical study showed high patient DIBH compliance during both CT simulation and treatment for patients with lung cancer. A significant reduction in target volumes was achieved with SBRT in DIBH, in addition to significantly decreased doses to the heart, chest wall, and lungs. DIBH in SBRT of lung lesions is feasible, and a routine to manage intra-fractional deviation should be established upon implementation.

Bidragsytere

Siri Tessem Mørkeset

  • Tilknyttet:
    Forfatter
    ved Klinikk for kreftbehandling og rehabilitering ved Helse Møre og Romsdal HF

Christoffer Lervåg

  • Tilknyttet:
    Forfatter
    ved Klinikk for kreftbehandling og rehabilitering ved Helse Møre og Romsdal HF

Jo-Åsmund Lund

  • Tilknyttet:
    Forfatter
    ved Klinikk for kreftbehandling og rehabilitering ved Helse Møre og Romsdal HF
  • Tilknyttet:
    Forfatter
    ved Institutt for helsevitenskap Ålesund ved Norges teknisk-naturvitenskapelige universitet

Christer André Jensen

  • Tilknyttet:
    Forfatter
    ved Institutt for helsevitenskap Ålesund ved Norges teknisk-naturvitenskapelige universitet
  • Tilknyttet:
    Forfatter
    ved Fagavdelinga ved Helse Møre og Romsdal HF
1 - 4 av 4